Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study

Table 1

Baseline information of all participants.

Parameters	WK^* treatment (91 cases)	Sotalol treatment (89 cases)	value ( value)^**
Hyperthyroidism history (years)	8.374 ± 2.619	8.551 ± 2.680	0.448 (0.655)
PAF^* history (years)	4.099 ± 1.599	4.213 ± 1.675	0.469 (0.639)
FT3^* (pmol/L)	24.613 ± 5.059	24.405 ± 5.006	−0.278 (0.781)
FT4^* (pmol/L)	118.697 ± 29.213	116.132 ± 28.266	−0.598 (0.550)
TSH^* (IU/mL)	0.007 ± 0.010	0.009 ± 0.015	1.191 (0.235)

WK: Wenxin Keli, PAF: paroxysmal atrial fibrillation, FT3: free triiodothyronine, FT4: free thyroxine, and TSH: thyroid stimulating hormone; ^**analyzed by independent samples -test.